Comments on:

Obama's fiscal cliff drug 'reform' idea will backfire

Back to the article » |
As part of the fiscal cliff negotiations, the White House has trotted out a deeply misguided healthcare idea. The President has his allies want to loosen "intellectual property" protection for an advanced class of pharmaceuticals called "biologics." This is a mistake. Including this plan in any federal budget deal would inevitably undermine drug innovation, compromise care for millions of...